hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06301204, orgStudyIdInfo id: 21.06.2022-E.67046, briefTitle: Effectiveness Of Tranexamic Acıd Application Wıth Different Doses On Bleeding, Edema And Physician Comfort In Orthognathıc Surgery Patients, statusModule overallStatus: COMPLETED, startDateStruct date: 2022-03-01, primaryCompletionDateStruct date: 2023-11-01, completionDateStruct date: 2023-11-01, studyFirstPostDateStruct date: 2024-03-08, lastUpdatePostDateStruct date: 2024-03-08, sponsorCollaboratorsModule leadSponsor name: Bezmialem Vakif University, class: OTHER, descriptionModule briefSummary: The aim of this clinical study conducted in accordance with the information in the literature is to compare the effects of administering tranexamic acid during orthognathic surgery, at different doses. Specifically, investigators aim to compare the effects of administering 1 ampoule IV (approximately 3 mg/kg) and 2 ampoules IV (approximately 6 mg/kg), and evaluate their impact on intraoperative bleeding (ml), surgical duration (min), postoperative swelling, and intraoperative surgical field evaluation (Fromme Scale), by comparing them with control group (applying no drug administration) patient data., conditionsModule conditions: Tranexamic Acid, conditions: Orthognathic Surgery, conditions: Edema, conditions: Bleeding, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: PREVENTION, maskingInfo masking: SINGLE, whoMasked: PARTICIPANT, enrollmentInfo count: 60, type: ACTUAL, armsInterventionsModule interventions name: Tranexamic acid injection, interventions name: Saline, outcomesModule primaryOutcomes measure: intraoperative bleeding during the surgery (ml), secondaryOutcomes measure: postoperative edema calculation for the first 1-3 and 7 day (cm), secondaryOutcomes measure: intraoperative surgical site evaluation (Fromme Scale), secondaryOutcomes measure: Hemoglobin (Hgb) and Hematocrit (Hct) values alteration preoperative and postoperative 2. day, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 65 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Bezmialem Vakıf Universty, city: Istanbul, state: Fatih, zip: 34093, country: Turkey, geoPoint lat: 41.01384, lon: 28.94966, hasResults: False
protocolSection identificationModule nctId: NCT06301191, orgStudyIdInfo id: 133/21-02-2022, briefTitle: The Effect of Semaglutide on Cardiovascular Markers and Liver Function, statusModule overallStatus: RECRUITING, startDateStruct date: 2022-03-01, primaryCompletionDateStruct date: 2023-03-01, completionDateStruct date: 2024-05-01, studyFirstPostDateStruct date: 2024-03-08, lastUpdatePostDateStruct date: 2024-03-08, sponsorCollaboratorsModule leadSponsor name: Attikon Hospital, class: OTHER, descriptionModule briefSummary: Fifty patients with diabetes mellitus type 2 and non-alcoholic fatty liver disease (NAFLD) will be enrolled in the study.25 patients will treated with semaglutide and 25 patients with dipeptidyl peptidase 4 (D-PP4) inhibitors.At baseline, at four and at 12 months will evaluate the endothelial, cardiovascular and liver function., conditionsModule conditions: Diabetes Type 2, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_CONTROL, timePerspective: PROSPECTIVE, enrollmentInfo count: 50, type: ESTIMATED, armsInterventionsModule interventions name: Semaglutide, 1.0 mg/mL, interventions name: Dipeptidyl Peptidase 4 inhibitor, outcomesModule primaryOutcomes measure: Comparison of arterial stiffness markers difference among treatment groups, primaryOutcomes measure: Comparison of endothelial glycocalyx thickness difference among treatment groups, primaryOutcomes measure: Comparison of liver stiffness difference among treatment groups, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 80 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Attikon University General Hospital, status: RECRUITING, city: Athens, zip: 12462, country: Greece, contacts name: Vaia Lambadiari, Professor, role: CONTACT, phone: 2105831148, email: vlambad@otenet.gr, geoPoint lat: 37.97945, lon: 23.71622, hasResults: False
protocolSection identificationModule nctId: NCT06301178, orgStudyIdInfo id: 12548, briefTitle: Effect of Vitamin D Injection on Hypertrophic Scars and Keloids, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-02-27, primaryCompletionDateStruct date: 2025-02-20, completionDateStruct date: 2026-02-20, studyFirstPostDateStruct date: 2024-03-08, lastUpdatePostDateStruct date: 2024-03-21, sponsorCollaboratorsModule leadSponsor name: Mostafa Bahaa, class: OTHER, descriptionModule briefSummary: Scars and keloids cause patients severe morbidity and psychological distress. Hypertrophic scars rise above the skin but stay within the scar boundaries, while keloids expand.The development of keloids and hypertrophic scars is a consequence of insufficient wound healing. These lesions are distinguished by excessive ECM deposition. Excessive ECM deposition is caused by increased inflammatory and proliferative processes and decreased remodeling activities. These scarring lesions are also linked to genetic and systemic causes, conditionsModule conditions: Dermatologic Disease, designModule studyType: INTERVENTIONAL, phases: PHASE1, phases: PHASE2, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 35, type: ESTIMATED, armsInterventionsModule interventions name: Cholecalciferol, outcomesModule primaryOutcomes measure: Clinical scoring by Vancouver Scale Score, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 50 Years, stdAges: ADULT, contactsLocationsModule locations facility: faculty of medicine-Fayoum university, status: RECRUITING, city: Fayoum, zip: 63519, country: Egypt, contacts name: Marwa Kamal, PhD, role: CONTACT, phone: 01021365897, email: mka05@fayou.edu.eg, geoPoint lat: 29.30995, lon: 30.8418, hasResults: False
protocolSection identificationModule nctId: NCT06301152, orgStudyIdInfo id: E2-22-1905, briefTitle: Lateral Epicondylitis Treatment High Intensive Laser Therapy and Extracorporeal Shock Wave Therapy, statusModule overallStatus: COMPLETED, startDateStruct date: 2022-09-01, primaryCompletionDateStruct date: 2022-10-01, completionDateStruct date: 2023-05-30, studyFirstPostDateStruct date: 2024-03-08, lastUpdatePostDateStruct date: 2024-03-08, sponsorCollaboratorsModule leadSponsor name: Ankara City Hospital Bilkent, class: OTHER, descriptionModule briefSummary: Objectives: This study aims to evaluate and compare the short-term efficacy of high-intensity laser therapy (HILT) and extra corporeal shock wave therapy(ESWT) on pain, sensitivity, handgrip strength, and functions in the treatment of lateral epicondylitis (LE).Material and methods: Forty five participants (age range, 18 to 65 years) with unilateral elbow pain were randomized into two groups. HILT group (n = 22) and the ESWT group (n = 23). The HILT and ESWT were administered three times a week for three weeks, and each treatment was combined with exercises. All patients in both groups were evaluated with ultrasonography for common extensor tendon(CET) thickness. A visual analog scale (VAS), Quick Disabilities of the Arm, Shoulder, and Hand (QDASH), and hand grip strength test were used to evaluate the patients before, one, and six weeks after treatment., conditionsModule conditions: Lateral Epicondylitis, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: two different treatment modalities were applied in two groups, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 40, type: ACTUAL, armsInterventionsModule interventions name: high intensive laser, interventions name: extracorporeal shock wave therapy, outcomesModule primaryOutcomes measure: Visual analog scale, secondaryOutcomes measure: Quick Disability Arm, Shoulder and Hand questionary,, secondaryOutcomes measure: hand grip strength, secondaryOutcomes measure: musculoskeletal ultrasonography, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 65 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Emine Esra Bilir, city: Ankara, state: Çankaya, zip: 06800, country: Turkey, geoPoint lat: 39.91987, lon: 32.85427, hasResults: False
protocolSection identificationModule nctId: NCT06301139, orgStudyIdInfo id: P17-004, briefTitle: Goat Milk Infant Formula Comfort Study, statusModule overallStatus: COMPLETED, startDateStruct date: 2019-05-01, primaryCompletionDateStruct date: 2021-04-01, completionDateStruct date: 2024-02-01, studyFirstPostDateStruct date: 2024-03-08, lastUpdatePostDateStruct date: 2024-03-08, sponsorCollaboratorsModule leadSponsor name: Ausnutria Hyproca B.V., class: INDUSTRY, collaborators name: HM hospitales, descriptionModule briefSummary: In this study, the investigators aim to assess that infants with mild symptoms have significantly less (severe) symptoms after 14 days goat milk-based formula use compared to infants using cow's milk-based formula supplemented with probiotic drops., conditionsModule conditions: Gastrointestinal Diseases, conditions: Cow's Milk Intolerance, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: randomized controlled pilot study, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 18, type: ACTUAL, armsInterventionsModule interventions name: Goat milk-based infant formula, interventions name: Cow's milk-based infant formula with probiotic drops, outcomesModule primaryOutcomes measure: Cow's Milk-related Symptoms, secondaryOutcomes measure: Cow's Milk-related Symptoms, secondaryOutcomes measure: Parental stress, secondaryOutcomes measure: Parental quality of life, secondaryOutcomes measure: Weight, secondaryOutcomes measure: Length, secondaryOutcomes measure: Weight-for-age, secondaryOutcomes measure: Length-for-age, secondaryOutcomes measure: Weight-for-length, eligibilityModule sex: ALL, minimumAge: 6 Weeks, maximumAge: 3 Months, stdAges: CHILD, contactsLocationsModule locations facility: HM hospitales, city: Madrid, zip: 28015, country: Spain, geoPoint lat: 40.4165, lon: -3.70256, hasResults: False
protocolSection identificationModule nctId: NCT06301126, orgStudyIdInfo id: P.T.REC/012/004985, briefTitle: Virtual Reality on Pulmonary Function After Upper Abdominal Surgeries, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03-01, primaryCompletionDateStruct date: 2025-02-01, completionDateStruct date: 2025-03-01, studyFirstPostDateStruct date: 2024-03-08, lastUpdatePostDateStruct date: 2024-03-12, sponsorCollaboratorsModule leadSponsor name: Cairo University, class: OTHER, descriptionModule briefSummary: After upper abdomen surgery, respiratory muscle dysfunction is well recognised. After laparotomy and even laparoscopy, maximum static inspiratory and expiratory pressures are lowered, and recovery can take several days. A variety of reasons have been implicated in such respiratory muscle dysfunction, including irritation and inflammation, as well as injuries near the diaphragm, resulting in local mechanical failure, reflex inhibition, and pain., conditionsModule conditions: Abdomen Hernia, conditions: Respiratory Complication, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, whoMasked: INVESTIGATOR, enrollmentInfo count: 60, type: ESTIMATED, armsInterventionsModule interventions name: Virtual reality, interventions name: conventional physical therapy exercise program, outcomesModule primaryOutcomes measure: Forced vital capacity (FVC), secondaryOutcomes measure: Forced expiratory volume in 1 second (FEV1), secondaryOutcomes measure: Peak expiratory flow (PEF), secondaryOutcomes measure: Respiratory muscle strength, secondaryOutcomes measure: diaphragmatic mobility, secondaryOutcomes measure: Functional capacity, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 60 Years, stdAges: ADULT, contactsLocationsModule locations facility: Faculty of Physical Therapy, status: RECRUITING, city: Giza, zip: 12111, country: Egypt, contacts name: Nesma M Allam, PhD, role: CONTACT, phone: +201281968332, email: dr.nesma2011@yahoo.com, geoPoint lat: 30.00808, lon: 31.21093, hasResults: False
protocolSection identificationModule nctId: NCT06301113, orgStudyIdInfo id: IRB#: 01202023_torabiDH_CBDloz, briefTitle: This Research Study Examines the Effects of Cannabidiol-infused Candy on Reducing the Bacteria Causing Tooth Decay, When Comparing it to a Sugar Free Candy on Adults., statusModule overallStatus: COMPLETED, startDateStruct date: 2023-01-27, primaryCompletionDateStruct date: 2023-02-11, completionDateStruct date: 2023-02-11, studyFirstPostDateStruct date: 2024-03-08, lastUpdatePostDateStruct date: 2024-03-08, sponsorCollaboratorsModule leadSponsor name: West Coast University, class: OTHER, descriptionModule briefSummary: The goal of this clinical trial is to compare the effect of CBD candy versus sugar free candy on reducing the number of bacteria causing tooth decay, in adults The main question is to see whether CBD have any effect on reducing the number of Streptococcus mutans, in the oral cavity the main bacteria causing tooth decay.Participants will be randomly placed in a group, and assigned to take either CBD-infused lozenge (if in the experimental group) or a sugar-free candy (if in the control group) once a day for 15 days.A sample of saliva will be collected and analyzed in a lab before and after consumption of the candy to see whether either product could reduce the harmful bacteria in the mouth., conditionsModule conditions: Tooth Decay, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: 30 Participants were randomly assigned to groups A (experimental group)and B (Control group)., primaryPurpose: BASIC_SCIENCE, maskingInfo masking: NONE, enrollmentInfo count: 30, type: ACTUAL, armsInterventionsModule interventions name: CBD infused candy, interventions name: Sugar free Candy, outcomesModule primaryOutcomes measure: To investigate the impact of CBD-infused lozenges on Streptococcus mutans, by employing quantitative polymerase chain reaction (qPCR) for bacterial analysis., eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: West Coast University, city: Anaheim, state: California, zip: 92802, country: United States, geoPoint lat: 33.83529, lon: -117.9145, hasResults: False
protocolSection identificationModule nctId: NCT06301100, orgStudyIdInfo id: E20230371, briefTitle: Single-center, Prospective Study on the Identification and Delineation of Brain and Lung Tumors and At-Risk Organs, and Functional Testing of Surrounding Tissues Based on Dual-Energy CT, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-04-28, primaryCompletionDateStruct date: 2024-04-28, completionDateStruct date: 2024-12-31, studyFirstPostDateStruct date: 2024-03-08, lastUpdatePostDateStruct date: 2024-03-08, sponsorCollaboratorsModule leadSponsor name: Tianjin Medical University Cancer Institute and Hospital, class: OTHER, descriptionModule briefSummary: This study explored the feasibility of dual-energy CT in head and lung tumors. Dual-energy CT can achieve quantitative CT imaging based on traditional imaging by dual-energy spectral imaging, and enhance the clarity of head and lung tumors. In this study, we will prospectively explore the image accuracy and delineation accuracy of dual energy CT in radiotherapy to verify whether dual energy CT performs better with conventional CT., conditionsModule conditions: Image Quality and Contouring Accuracy of the Tumor in Radiotherapy, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 50, type: ESTIMATED, armsInterventionsModule interventions name: Dual energy CT after routine simulation, outcomesModule primaryOutcomes measure: DICE value, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Huan-Hu-Xi, status: RECRUITING, city: Tianjin, state: Tianjin, zip: 300381, country: China, contacts name: Zhiyong Yuan, Doctor, role: CONTACT, phone: +86 186 2222 1199, email: zyuan@tmu.edu.cn, geoPoint lat: 39.14222, lon: 117.17667, hasResults: False
protocolSection identificationModule nctId: NCT06301087, orgStudyIdInfo id: WP-2024-01, briefTitle: Early Detection Neurodevelopmental Disorders of Children and Prevention of Postnatal Depression by Mobile Health App, statusModule overallStatus: COMPLETED, startDateStruct date: 2022-05-01, primaryCompletionDateStruct date: 2024-02-08, completionDateStruct date: 2024-02-08, studyFirstPostDateStruct date: 2024-03-08, lastUpdatePostDateStruct date: 2024-03-15, sponsorCollaboratorsModule leadSponsor name: Weprom, class: OTHER, collaborators name: Kelindi, descriptionModule briefSummary: The goal of this observational study is to confirm the impact of using this app adapted to be more specific for screening for 5 neurodevelopmental disorders and to evaluate the mothers' support program on the incidence of postpartum depression in of young parents with a minimum of 1 child under 10 years of age at the time of inclusion and using Malo on a regular basis. The main questions it aims to answer are :* the median age of possible neurodevelopmental disorders notification of infants* the median time of the mothers' postnatal depression notifications after childbirth subsequently to the support and prevention program Participants will agree with use of their data, conditionsModule conditions: Development, Child, conditions: Postnatal Depression, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: CROSS_SECTIONAL, enrollmentInfo count: 55618, type: ACTUAL, armsInterventionsModule interventions name: Web Application, outcomesModule primaryOutcomes measure: Time to neurodevelopment desorder diagnostic, secondaryOutcomes measure: User's satisfaction, secondaryOutcomes measure: Relevance of the neurodevelopmental desorder notification, secondaryOutcomes measure: Rate of mothers'postnal depression, secondaryOutcomes measure: Time of mothers'postnatal depression, eligibilityModule sex: ALL, maximumAge: 10 Years, stdAges: CHILD, contactsLocationsModule locations facility: ILC, city: Le Mans, country: France, geoPoint lat: 48.0, lon: 0.2, hasResults: False
protocolSection identificationModule nctId: NCT06301061, orgStudyIdInfo id: PB001, briefTitle: Focal Microvibration and Chronic Lumbosacral Radicular Pain, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-01, primaryCompletionDateStruct date: 2025-10-01, completionDateStruct date: 2026-04-01, studyFirstPostDateStruct date: 2024-03-08, lastUpdatePostDateStruct date: 2024-03-08, sponsorCollaboratorsModule leadSponsor name: Federico II University, class: OTHER, descriptionModule briefSummary: The goal of this clinical trial is to investigate the effectiveness of focal microvibration on patients affected by chronic lumbosacral radicular pain. The main question\[s\] it aims to answer are:* Can focal microvibration improve pain in this patient population?* Can focal microvibration improve quality of life in these patients? Participants will attach to their skin four little devices (10x20x0,5mm) delivering focal microvibration in the painful area according to researchers indications for 6 hours/day every day except Thursday and Sunday.Researchers will compare patients treated with focal microvibration to patients treated with a sham device and to patients treated with standard pharmacological therapy., conditionsModule conditions: Pain, Chronic, conditions: Lumbosacral Radiculopathy, conditions: Radicular; Neuropathic, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, whoMasked: PARTICIPANT, enrollmentInfo count: 150, type: ESTIMATED, armsInterventionsModule interventions name: Equistasi®, interventions name: Sham, interventions name: Gabapentin; Pregabalin; Duloxetine; Amitriptyline, outcomesModule primaryOutcomes measure: Pain intensity, secondaryOutcomes measure: Pain interference in daily life, secondaryOutcomes measure: Disability, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, hasResults: False
protocolSection identificationModule nctId: NCT06301048, orgStudyIdInfo id: BFHHZS20230203, briefTitle: Effectiveness of Endoscopic Papillectomy With Stent for Treating Duodenal Papillary Adenoma, statusModule overallStatus: COMPLETED, startDateStruct date: 2023-11-07, primaryCompletionDateStruct date: 2023-12-07, completionDateStruct date: 2023-12-07, studyFirstPostDateStruct date: 2024-03-08, lastUpdatePostDateStruct date: 2024-03-08, sponsorCollaboratorsModule leadSponsor name: Beijing Friendship Hospital, class: OTHER, descriptionModule briefSummary: This is a retrospective study, including 79 patients with duodenal papillary adenoma, who treated with Endoscopic Papillectomy (EP) at Beijing friendship hospital. The cohort included patients who underwent EP with or without Pancreatic Duct (PD) and Common Bile Duct (CBD) stent placement. The investigators assessed the outcomes of EP and the impact of stent placement on complications and recurrence rates., conditionsModule conditions: Duodenal Adenoma, conditions: Complication of Treatment, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: RETROSPECTIVE, enrollmentInfo count: 79, type: ACTUAL, armsInterventionsModule interventions name: Stent Placement in Pancreatic and Bile Ducts, outcomesModule primaryOutcomes measure: Rate of complications, primaryOutcomes measure: Rate of complete resection, secondaryOutcomes measure: Rate of recurrence, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Beijing Friendship Hospital, city: Beijing, state: Beijing, zip: 100050, country: China, geoPoint lat: 39.9075, lon: 116.39723, hasResults: False